Janet Kukreja, MD
Assistant Professor, Surgery-Urology

Photo
Download CV
Medical School:
  • MD, University of Missouri-Kansas City School of Medicine (2010)
Graduate School :
  • MPH, University of Rochester (2014)
Undergraduate School:
  • BA, University of Missouri–Kansas City (MO) (2009)
Residency:
  • University of Rochester Program, Chief Resident, Urology (2016)
Fellowships:
  • University of Texas at Houston/M D Anderson Cancer Center Program, Urologic Oncology (2018)
Languages: English
Department: Surgery-Urology

Professional Titles

  • Assistant Professor, Surgery-Urology
  • Urologic Oncologist

Recognition & Awards

  • John Quale Travel Fellowship, Bladder Cancer Advocacy Network (2017)
  • Outstanding Laparoendoscopic Resident Award, Society for Laparoendoscopic Surgeons (2017)

Research Interests

Bladder Cancer Prostate Cancer

Teaching

  • Assitant Professor (2018)
    School of Medicine, Surgery
    Bladder Cancer, Urologic Oncology

Publications

  • Baack Kukreja J, Bathala TK, Reichard CA, Troncoso P, Delacroix S, Davies B, Eggener S, Smaldone M, Minhaj Siddiqui M, Tollefson M, Chapin BF. Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer. Prostate Cancer Prostatic Dis. 2020 Mar;23(1):172-178. PubMed PMID: 31501508
  • Pessoa R, Navai N, Kukreja JB. EDITORIAL COMMENT. Urology. 2020 Jan;135:64-65. PubMed PMID: 31895682
  • Baack Kukreja JE, Lloyd G.L. Robotically Assisted Radical Cystectomy. In: Best S., Nakada S. (eds) Minimally Invasive Urology. Springer, New York, NY, 2019.
  • Baack Kukreja J. Venous Thromboembolism Prophylaxis in Urologic Surgery. AUA Update Series.
  • Reichard CA, Baack Kukreja J, Gregg JR, Bathala TK, Achim MF, Wang X, Davis JW, Nguyen QN, Chapin BF. Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial Design. Eur Urol Focus. May 2019;S2405-4569(19)30132-4. Epub ahead of print. PMID: 31076357
  • Li R, Kukreja JEB, Seif MA, Petros FG, Campbell MT, Nguyen JV, Conzalez GMN, Kamat AM, Pisters LL, Dinney CP, Navai N. The role of metastatic burden in cytoreductive/consolidative radical cystectomy. World J Urol Mar 2019. PMID: 30864005.
  • Kukreja JB, Thompson IM Jr, Chapin BF. Organizing a clinical trial for the new investigator. Urol Oncol. 2019 May;37(5):336-339. PMID 2939593.
  • Truong M, Baack Kukreja JE, Rais-Bahrami S, Barashi NS, Wang B, Nuffer Z, Park JH, Lam K, Frye TP, Nix JW, Thomas JV, Feng C, Chapin BF, Davis JW, Hollenberg G, Oto A, Eggener SE, Joseph JV, Weinberg E, Messing EM. Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging. Eur Urol Oncol. 2019 May;2(3):257-264. PubMed PMID: 31200839
  • Pessoa RR, Kukreja J. Editorial Comment. J Urol. 2019 Dec;202(6):1253. PubMed PMID: 31469612
  • Li R, Kukreja JEB, Seif MA, Petros FG, Campbell MT, Nguyen JV, González GMN, Kamat AM, Pisters LL, Dinney CP, Navai N. The role of metastatic burden in cytoreductive/consolidative radical cystectomy. World J Urol. 2019 Dec;37(12):2691-2698. PubMed PMID: 30864005
  • Berrondo C, Feng C, Kukreja JB, Messing EM, Joseph JV. Antibiotic prophylaxis at the time of catheter removal after radical prostatectomy: A prospective randomized clinical trial. Urol Oncol. 2018 Dec 14. [Epub ahead of print] PubMed PMID: 30558984
  • Joseph JV, Brasacchio R, Fung C, Reeder J, Bylund K, Sahasrabudhe D, Yeh SY, Ghazi A, Fultz P, Rubens D, Wu G, Singer E, Schwarz E, Mohile S, Mohler J, Theodorescu D, Lee YF, Okunieff P, McConkey D, Rashid H, Chang C, Fradet Y, Guru K, Kukreja J, Sufrin G, Lotan Y, Bailey H, Noyes K, Schwartz S, Rideout K, Bratslavsky G, Campbell SC, Derweesh I, Abrahamsson PA, Soloway M, Gomella L, Golijanin D, Svatek R, Frye T, Lerner S, Palapattu G, Wilding G, Droller M, Trump D. A Festschrift in Honor of Edward M. Messing, MD, FACS. Bladder Cancer. 2018 Oct 3;4(Suppl 1):S1-S43. PubMed PMID: 30443561
  • Kukreja JB, Metcalfe MJ, Qiao W, Kamat AM, Dinney CPN, Navai N. Cost-Effectiveness of Robot-assisted Radical Cystectomy Using a Propensity-matched Cohort. Eur Urol Focus. 2018 Jul 19. [Epub ahead of print] PubMed PMID: 30033071
  • Kukreja JB, Shi Q, Chang CM, Seif MA, Sterling BM, Chen TY, Creel KM, Kamat AM, Dinney CP, Navai N, Shah JB, Wang XS. Patient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical Cystectomy. Surg Innov. 2018 Jun;25(3):242-250. PubMed PMID: 29557251
  • Kukreja JEB. Perioperative venous thromboembolism in urologic oncology procedures, risk factors, and prevention. Curr Opin Urol. 2018 May;28(3):227-232. PubMed PMID: 29465471
  • Li R, Metcalfe M, Kukreja J, Navai N. Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review. Bladder Cancer. 2018 Jan 20;4(1):31-40. PubMed PMID: 29430505
  • Kukreja JB, Thompson IM Jr, Chapin BF. Organizing a clinical trial for the new investigator. Urol Oncol. 2018 Feb 1. [Epub ahead of print] PubMed PMID: 29395953
  • Li R, Baack Kukreja JE, Kamat AM. Secondary Tumors After Urinary Diversion. Urol Clin North Am. 2018 Feb;45(1):91-99. PubMed PMID: 29169454
  • Kukreja JB, Porten S, Golla V, Ho PL, Noguera-Gonzalez G, Navai N, Kamat AM, Dinney CPN, Shah JB. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. Eur Urol Focus. 2018 Sep;4(5):720-724. PubMed PMID: 28753837
  • Baack Kukreja J, Kamat AM. Strategies to minimize readmission rates following major urologic surgery. Ther Adv Urol. 2017 Oct;9(5):111-119. PubMed PMID: 28588648
  • Truong M, Liang L, Kukreja J, O'Brien J, Jean-Gilles J, Messing E. Cautery artifact understages urothelial cancer at initial transurethral resection of large bladder tumours. Can Urol Assoc J. 2017 May;11(5):E203-E206. PubMed PMID: 28503235
  • Baack Kukreja JE, Kiernan M, Schempp B, Siebert A, Hontar A, Nelson B, Dolan J, Noyes K, Dozier A, Ghazi A, Rashid HH, Wu G, Messing EM. Quality Improvement in Cystectomy Care with Enhanced Recovery (QUICCER) study. BJU Int. 2017 Jan;119(1):38-49. PubMed PMID: 27128851
  • Broughton BL, Baron B, Kiernan M, Baack-Kukreja J, LaFaro VE, Larmon R, Rust K, Schempp BA, Yovanovich J. Cystectomy-Enhanced Recovery Program: Nursing Implications. Urol Nurs. 2017 Jan-Feb;37(1):9-14. PubMed PMID: 29240359
  • Kukreja JB, Shah JB. Advances in surgical management of muscle invasive bladder cancer. Indian J Urol. 2017 Apr-Jun;33(2):106-110. PubMed PMID: 28469297
  • Li R, Petros FG, Kukreja JB, Williams SB, Davis JW. Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomy. Investig Clin Urol. 2016 Dec;57(Suppl 2):S155-S164. PubMed PMID: 27995219
  • Noyes K, Baack-Kukreja J, Messing EM, Schoeniger L, Galka E, Pan W, Xueya C, Fleming FJ, Monson JR, Mohile SG, Francone T. Surgical readmissions: results of integrating pre-, peri- and postsurgical care. Nurs Open. 2016 Jul;3(3):168-178. PubMed PMID: 27708827
  • Baack Kukreja JE, Messing EM, Shah JB. Are we doing "better"? The discrepancy between perception and practice of enhanced recovery after cystectomy principles among urologic oncologists. Urol Oncol. 2016 Mar;34(3):120.e17-21. PubMed PMID: 26585947
  • Danna BJ, Wood EL, Baack Kukreja JE, Shah JB. The Future of Enhanced Recovery for Radical Cystectomy: Current Evidence, Barriers to Adoption, and the Next Steps. Urology. 2016 Oct;96:62-68. PubMed PMID: 27164287
  • Kukreja JB, Messing EM. Editorial Comment. Urology. 2015 Nov;86(5):972-3. PubMed PMID: 26414727
  • Kukreja JE, Levey HR, Scosyrev E, Kiernan M, Berrondo C, McNamee C, Wu G, Joseph JV, Ghazi A, Rashid H, Dozier A, Messing EM. Effectiveness and safety of extended-duration prophylaxis for venous thromboembolism in major urologic oncology surgery. Urol Oncol. 2015 Sep;33(9):387.e7-16. PubMed PMID: 25637953
  • Baack Kukreja JE, Scosyrev E, Brasacchio RA, Toy EP, Messing EM, Wu G. Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer. BJU Int. 2014 Dec;114(6):844-51. PubMed PMID: 26010047
  • Lee EK, Baack J, Duchene DA. Survey of practicing urologists: robotic versus open radical prostatectomy. Can J Urol. 2010 Apr;17(2):5094-8. PubMed PMID: 20398448
  • Lee EK, Baack J, Penn H, Bromfield CT, Duchene DA, Thrasher JB, Holzbeierlein JM. Active surveillance for prostate cancer in a veteran population. Can J Urol. 2010 Dec;17(6):5429-35. PubMed PMID: 21172105
View All (33 Total) View Less

Professional Memberships

  • American College of Surgeons, Member
  • International Bladder Cancer Network, Member
  • American Urologic Association, Member
  • Society of Urologic Oncology, Member
  • Southwestern Oncology Group (SWOG), Investigator
  • Rocky Mountain Urologic Society, Member
  • Society of Women in Urology, Member
  • Institute for healthcare, quality, safety and efficiency, Faculty
  • South Centeral Section of the AUA, Member

Practice Locations

UCHealth Tony Grampsas Urologic Cancer Care Clinic - Anschutz Medical Campus
1665 Aurora Ct
1st Floor
Aurora, CO 80045
720-848-0170

Hospital Affiliation
  • University of Colorado Hospital
  • Denver Health Medical Center
  • Veterans Affairs Medical Center
  • UCHealth Highlands Ranch Hospital
Center Affiliations

Specialty Information

Specialties
  • Urology, Board Certification (2020, 2020)
  • Urologic Oncology, Certificate (2018)
Conditions & Treatments
  • Cancers - Bladder Cancer
  • Cancers
  • Cancers - Cancer Surgery
  • Cancers - Chemotherapy
  • Cancers - Kidney Cancer
  • Cancers - Prostate Cancer
  • Cancers - Testicular Cancer
  • Cancers - Urologic Cancer
  • Surgery
  • Surgery - Robotic Surgery
  • Surgery - Urologic Surgery
  • Failed Prior Surgery
  • Kidneys and Urinary System
  • Kidneys and Urinary System - Bladder Disease
Clinical Interests
I have particular interest in the treatment of urologic cancers including bladder, prostate, kidney, testicular, penile and ureteral cancers. I believe in providing the most advanced technology and care for patients with urologic cancers. I have a special interest in perioperative care. I offer the following procedures robotic bladder (cystectomy/cystoprostatectomy) and urinary diversion creation (Ileal conduit, Indiana Pouch and Neobladder. I also offer robotic removal of: adrenal glands, prostate (prostatectomy), kidney (nephrectomy), partial kidney (partial nephrectomy/nephron sparing surgery), minimally invasive surgery, retroperitoneal lymph node dissection, inguinal lymph node removal, ureteral removal (partial ureterectomy).

Care Philosophy
I believe in providing the best care for urologic cancer patients includes a multidisciplinary approach as well as the most advanced technology. Working with patients in developing a treatment plan is extremely important in the treatment of urologic cancers. Patients with urologic cancers often have unique needs and these must be recognized. I hope that through the latest developments in surgery and cancer care we can provide the best urologic cancer care. To date, I have performed 70+ robot assisted bladder removal cases (radical cystectomies).

Personal Interests
I am very passionate about all urologic cancers, specifically bladder cancer and prostate cancer. I have a particular interest in perioperative care for all cancer patients.

Public Speaking
Yes
I speak often about bladder cancer, surgery for bladder cancer and perioperative care for bladder cancer. I have also spoken about care for prostate cancer.

General Information

Medical Schools:
  • MD, University of Missouri-Kansas City School of Medicine (2010)
Graduate Schools:
  • MPH, University of Rochester (2014)
Undergraduate Schools:
  • BA, University of Missouri–Kansas City (MO) (2009)
Residency Programs:
  • University of Rochester Program, Chief Resident, Urology (2016)
Fellowships:
  • University of Texas at Houston/M D Anderson Cancer Center Program, Urologic Oncology (2018)
Download CV
Languages: English
Department: Surgery-Urology
;